← back to search

Arbel D. Tadmor

BioNTech (Germany) · DE
Area of research
Immunology · Molecular Biology
Research interest
Research interests include Immunotherapy and Immune Responses, Cancer Immunotherapy and Biomarkers, Bacteriophages and microbial interactions, and Genomics and Phylogenetic Studies.
h-index
13
citations
6,240
works
27
NIH funding
primary concept
Biology
email

Recent publications

Autogene cevumeran with or without atezolizumab in advanced solid tumors: a phase 1 trial
Nature Medicine 2025cited by 89position: middledoi
Identification and spatio-temporal tracking of ubiquitous phage families in the human microbiome
Frontiers in Microbiomes 2023cited by 4position: firstdoi
Key Parameters of Tumor Epitope Immunogenicity Revealed Through a Consortium Approach Improve Neoantigen Prediction
Cell 2020cited by 527position: middledoi
Multi-Omics Characterization of the 4T1 Murine Mammary Gland Tumor Model
Frontiers in Oncology 2020cited by 205position: middledoi
Publisher Correction: Actively personalized vaccination trial for newly diagnosed glioblastoma
Nature 2019cited by 15position: middledoi
Actively personalized vaccination trial for newly diagnosed glioblastoma
Nature 2018cited by 922position: middledoi
Challenges towards the realization of individualized cancer vaccines
Nature Biomedical Engineering 2018cited by 47position: middledoi
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Nature 2017cited by 2,430position: middledoi
Abstract A110: Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Cancer Immunology Research 2016cited by 13position: middledoi
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Nature 2015cited by 1,237position: middledoi
Abstract CT202: IVAC MUTANOME: Individualized vaccines for the treatment of cancer
Cancer Research 2015cited by 4position: middledoi
Immunomic, genomic and transcriptomic characterization of CT26 colorectal carcinoma
BMC Genomics 2014cited by 383position: middledoi
Mutated tumor alleles are expressed according to their DNA frequency
Scientific Reports 2014cited by 48position: middledoi
Spatiotemporal manipulation of retinoic acid activity in zebrafish hindbrain development via photo-isomerization
Development 2012cited by 15position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Uğur Şahin · Technical University of Munich6 papers (2014–2020)Sebastian Boegel · Johannes Gutenberg University Mainz5 papers (2014–2020)Özlem Türeci · Helmholtz Institute for Translational Oncology Mainz5 papers (2014–2018)Mustafa Diken · Gutenberg College4 papers (2014–2016)Martin Löwer · Johannes Gutenberg University Mainz4 papers (2015–2020)Sebastian Kreiter · Gutenberg College4 papers (2014–2016)Barbara Schrörs · Johannes Gutenberg University Mainz3 papers (2015–2020)Mathias Vormehr · BioNTech (Germany)3 papers (2015–2020)John C. Castle · University Hospitals Sussex NHS Foundation Trust3 papers (2014–2015)Claudia Paret · German Cancer Research Center2 papers (2014–2014)Niels van de Roemer · Johannes Gutenberg University Mainz2 papers (2015–2016)Thomas Bukur · Johannes Gutenberg University Mainz2 papers (2014–2020)Fulvia Vascotto · Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg-Universität Mainz2 papers (2015–2016)Martin Löewer · Johannes Gutenberg University Mainz2 papers (2014–2014)Jan Diekmann · Johannes Gutenberg University Mainz2 papers (2015–2016)Jos de Graaf · Johannes Gutenberg University Mainz2 papers (2014–2014)Valesca Boisguérin · Johannes Gutenberg University Mainz2 papers (2014–2014)Patrick Sorn · Johannes Gutenberg University Mainz1 papers (2014–2014)Stephen P. Schoenberger · La Jolla Institute for Immunology1 papers (2015–2015)Christoph Holtsträter · Johannes Gutenberg University Mainz1 papers (2020–2020)